CD8+ T Cells in Head and Neck Cancer
Author Information
Author(s): Kuss I, Donnenberg A D, Gooding W, Whiteside T L
Primary Institution: University of Pittsburgh Cancer Institute
Hypothesis
The study investigates the frequency and functional characteristics of effector CD8+ T cells in patients with squamous cell carcinoma of the head and neck.
Conclusion
Effector CD8+CD45RO−CD27− T cells are increased in patients with head and neck cancer but are dysfunctional and prone to apoptosis.
Supporting Evidence
- Patients with head and neck cancer have a higher frequency of CD8+CD45RO−CD27− T cells compared to normal controls.
- These effector T cells in cancer patients show low ζ expression, indicating dysfunctional signaling.
- More CD8+ T cells in cancer patients bind Annexin V, suggesting increased apoptosis.
Takeaway
In patients with head and neck cancer, a type of immune cell called CD8+ T cells are more common but not working properly, which might make it harder for the body to fight the cancer.
Methodology
Blood samples were taken from patients with squamous cell carcinoma and normal controls to analyze CD8+ T-cell subsets and their characteristics.
Potential Biases
The study may have biases due to the non-matching of age between patients and controls.
Limitations
The cohorts of patients and normal controls were not age matched, which could affect the results.
Participant Demographics
The patient group included 33 men and 6 women with a mean age of 61 years, while the control group had 11 males and 34 females with a mean age of 51 years.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website